BPI on the ALBVVG legislative process: Use the opportunity to fight drug shortages now!

“According to the current status, the ALBVVG still does not solve the supply bottleneck problems for over 98 percent of primary care medicines,” says Dr. Kai Joachimsen, General Manager at the Federal Association of the Pharmaceutical Industry (BPI) in the run-up to the public hearing of the Health Committee in the Bundestag. “Now we’re dealing with a chronic illness…